Cabaletta Bio
CABA
CABA
62 hedge funds and large institutions have $36.9M invested in Cabaletta Bio in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
-4
Holders Change %
-6.06%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
18
Reduced
17
Closed
12
Calls
$923K
Puts
$28K
Net Calls
+$895K
Net Calls Change
-$532K
Top Buyers
| 1 |
SC
1
Samlyn Capital
New York
|
$3.59M |
| 2 |
O
2
OrbiMed
New York
|
$1.17M |
| 3 |
3
Millennium Management
New York
|
$733K |
| 4 |
4
Renaissance Technologies
New York
|
$405K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$2.14M |
